Pulpotomy Medications in Primary Teeth

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 2, 2022

Primary Completion Date

July 12, 2024

Study Completion Date

August 5, 2024

Conditions
Drug Effect
Interventions
PROCEDURE

pulpotomy procedure and Histological evaluation

Sixty primary teeth in thirty children aged 7-9 years selected from Outpatient dental clinic Pedodontic and Endodontic Departments, Suez Canal University. divided into group I includes 30 teeth treated with ACTIVA BioACTIVE Base/Liner and group II includes 30 teeth treated by MTA with standard pulpotomy procedure Patients will be recalled after 15 and 30-days . 15 teeth from group I and 15 teeth from group II will be extracted after 15 days then subjected to decalcification then15 teeth from group I and 15 teeth from group II will be extracted after 30 days \& subjected to decalcification procedure in 20% EDTA at 4 °C for approximately 5 weeks then embedded in paraffin. Serial sections will be cut at 5 µm thickness. Deparaffinize the sections by 2 changes of xylene for 10 minutes each. Stain in Harris hematoxylin solution for 8 minutes. mount with xylene based mounting medium for conventional histological assessment using light microscope

DIAGNOSTIC_TEST

Immunohistochemistry Protocol for Fibronectin Antibody

"1. Deparaffinization/Rehydration~ * Slides heated in an oven at 65C for 1 hour.~ * De-paraffinization~2. Antigen Retrieval~ * Immersion of slides into staining dish containing Antigen Retrieval Solution.~ * Placing the staining dish into rice cooker.~ * When turned to warm, unplug cooker~ * Allow to cool down for 20 min~3. Staining~ * Wash slides with TBST for 5 min on a shaker.~ * Inactivate endogenous peroxidase by 3% hydrogen peroxide for 10 min.~ * Block slides with blocking solution for 1 hour.~ * Dilute primary antibody in blocking buffer~ * Apply primary antibody to each section and incubate overnight in humidified chamber~ * Wash slides three times with TBST"

DIAGNOSTIC_TEST

Immunohistochemistry Protocol for Osteopontin Antibody

will be carried out via avidin-biotin-peroxidase complex method using a VECTASTAIN ABC Kit . Sections will be deparaffinized by xylene and graded ethanol then treated with 20 µg/ml Proteinase K for 10 min. to prevent endogenous peroxidase activity, sections is incubated for 30 min in 0.3% H2O2/methanol then treated with 0.1% blocking serum albumin and incubated with primary antibody for 30 min. Rabbit polyclonal anti-osteopontin and goat polyclonal anti-RANKL will be used. dilution of primary antibodies used will be osteopontin (1 : 6000-8000). After being washed with phosphate-buffered saline several times, sections will be incubated with biotinylated IgG for 30 min and subsequently with streptavidin-horseradish peroxidase for 30 min. Following several washes with phosphate-buffered saline, 3,3'-diaminobenzidine substrate will be applied. As a negative control, non-immune serum will be used instead of primary antibody.

Trial Locations (1)

Unknown

Suez Canal University, Ismailia

All Listed Sponsors
lead

Suez Canal University

OTHER